Drooid Logo
Back to story perspectives

Full Breakdown

New Insights into IVF Genetic Testing Raise Questions About Embryo Viability

10/24/2025, 1:28:10 PM

Overview of the Study

Recent research from the Loke Centre for Trophoblast Research at the University of Cambridge has challenged the reliability of preimplantation genetic testing for aneuploidy (PGT-A), a common procedure used in in vitro fertilization (IVF) to assess embryo viability. The study reveals that genetic abnormalities can develop in embryos after the point of testing, particularly in cells destined to form the placenta, which may not impact the health of the fetus.

Key Findings

The study utilized advanced light-sheet microscopy to observe 13 human embryos over a continuous 46-hour period, marking the longest observation of this process to date. Researchers found that approximately 10% of the cells exhibited chromosomal abnormalities, primarily in the outer layer of the blastocyst, which develops into the placenta. This suggests that PGT-A may overestimate the number of embryos with significant genetic issues, as abnormalities detected in the outer cells may not affect the embryo's viability.

Dr. Ahmed Abdelbaki, the study's first author, noted, “This gentle yet high-resolution technique permitted continuous monitoring over a two-day interval, unveiling dynamic processes that were hitherto obscured.” The findings indicate that errors in chromosome segregation can occur late in development, raising questions about the clinical utility of current testing protocols that often lead to the discarding of embryos based on these results.

Implications for IVF Practices

The implications of this research are significant for fertility clinics that rely on PGT-A to determine embryo viability. Professor Kathy Niakan, director of the Loke Centre, emphasized that “errors in chromosome segregation can occur at comparatively late stages, specifically within the trophoblast—the precursor to the placenta—rather than within the inner cell mass that leads to the fetus.” This challenges the assumption that all detected aneuploidies are detrimental to embryo viability.

Criticism & Opposition

While the study presents groundbreaking findings, it also highlights the need for further research. Lilli Zimmerman, a researcher at Northwell Health, stated, “What this study, to me, really shows is that there is still a lot more research needed in terms of screening embryos for whether [they] are genetically normal or abnormal.” The study's limited sample size raises questions about the generalizability of the results.

Official Statements & Responses

The research was supported by institutions including Wellcome and the Francis Crick Institute. The findings were published in *Nature Biotechnology*, prompting discussions within the scientific community about the future of embryo screening techniques.

What's Next

The research team plans to investigate whether similar chromosomal abnormalities can arise in the inner cell layer of embryos, which develops into the fetus. This ongoing research aims to refine embryo screening methods and improve the success rates of assisted conception.

Verbatim Quotes

  • “Our research demonstrates that errors in chromosome segregation can occur at comparatively late stages, specifically within the trophoblast—the precursor to the placenta—rather than within the inner cell mass that leads to the fetus. This challenges the assumption that all detected aneuploidies are detrimental to embryo viability.” — Professor Kathy Niakan, Director of the Loke Centre for Trophoblast Research
  • “First author Dr Ahmed Abdelbaki, a postdoctoral researcher at the Loke Centre for Trophoblast Research, said: "This is the first time that this very gentle method, with much higher resolution, has been used.” — Dr. Ahmed Abdelbaki, Postdoctoral Researcher at the Loke Centre for Trophoblast Research
  • “Professor Niakan, the study's senior author, said: "We were extremely surprised to discover that abnormal cell divisions can happen from scratch at a very late stage of human development.” — Professor Kathy Niakan, Director of the Loke Centre for Trophoblast Research

This study underscores the complexities of embryo development and the necessity for ongoing research to enhance the efficacy of IVF practices.